Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.

Community Practice Connections™: How Can Pathologic Assessment Be Optimized for Patients with Acute Myeloid Leukemia?

Release Date: March 27, 2020
Expiration Date: March 27, 2021

Activity Overview

Community Practice Connections™: How Can Pathologic Assessment Be Optimized for Patients with Acute Myeloid Leukemia? focuses on optimizing pathologic assessment for patients with AML. Listen to oncology experts update pathologists with the latest information regarding diagnostic guidelines in AML, emerging targeted treatment strategies, and the application of novel diagnostic and therapeutic strategies in clinical practice. As understanding of the pathobiology of AML continues to evolve, the role of the pathologist in executing testing to guide the use of novel treatment strategies will continue to expand.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.


Target Audience

This educational program is directed toward pathologists and medical oncologists who treat patients with AML. Nurses, nurse practitioners, physician assistants, and other healthcare professions (HCPs) involved in the treatment and management of hematologic malignancies, specifically AML, are also invited to participate in the activity.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Identify recent changes and current recommendations in AML pathology and molecular testing as described by the ASH-CAP guidelines.
  • Outline strategies to improve multidisciplinary communication between the pathologist, oncologist, and other team members to optimize testing, reporting, and treatment for patients with AML.
  • Evaluate emerging data regarding mutational testing and treatment strategies based on these results.
  • Compare and contrast molecular testing methodologies available and their use for diagnosis and treatment planning for patients with AML.

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Faculty

Daniel A. Arber, MD
Daniel A. Arber, MD
Donald West and Mary Elizabeth King Professor of Pathology
Chair, Department of Pathology
University of Chicago
Chicago, IL

Disclosures: no relevant financial relationships with commercial interests.

Tapan M. Kadia, MD
Tapan M. Kadia, MD
Associate Professor
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX

Disclosures: Grant Research Support: Bristol-Myers Squibb, Amgen, Celgene, AbbVie, Genentech, Pfizer; Consultant: AbbVie, Pfizer, Novartis, Daiichi Sankyo.

The staff Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
    123
45678910
11121314151617
18192021222324
252627282930
Filter By